In Vivo Investigation of Novel Nano-vesicles of Salbutamol Sulphate

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 5, 2017

Primary Completion Date

February 5, 2017

Study Completion Date

February 5, 2017

Conditions
Drug EffectPulmonary Disease
Interventions
DRUG

Salbutamol Sulphate

salbutamol sulphate packaged as aerosol

DRUG

Niosomes

Niosomes

All Listed Sponsors
lead

British University In Egypt

OTHER

NCT03059017 - In Vivo Investigation of Novel Nano-vesicles of Salbutamol Sulphate | Biotech Hunter | Biotech Hunter